These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34254405)

  • 21. Efficacy and acceptability of atypical antipsychotics for the treatment of post-traumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
    Liu XH; Xie XH; Wang KY; Cui H
    Psychiatry Res; 2014 Nov; 219(3):543-9. PubMed ID: 25015709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.
    Rothbaum BO; Price M; Jovanovic T; Norrholm SD; Gerardi M; Dunlop B; Davis M; Bradley B; Duncan EJ; Rizzo A; Ressler KJ
    Am J Psychiatry; 2014 Jun; 171(6):640-8. PubMed ID: 24743802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
    Scheeringa MS; Weems CF
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM
    J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder.
    Parmenter ME; Lederman S; Weathers FW; Davis LL; Vaughn B; Engels J; Sullivan GM
    Psychiatry Res; 2024 Apr; 334():115764. PubMed ID: 38350291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats.
    Becker R; Gass N; Kußmaul L; Schmid B; Scheuerer S; Schnell D; Dorner-Ciossek C; Weber-Fahr W; Sartorius A
    Psychopharmacology (Berl); 2019 Dec; 236(12):3451-3463. PubMed ID: 31267156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects.
    Sanacora G; Smith MA; Pathak S; Su HL; Boeijinga PH; McCarthy DJ; Quirk MC
    Mol Psychiatry; 2014 Sep; 19(9):978-85. PubMed ID: 24126931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.
    Tucker P; Trautman RP; Wyatt DB; Thompson J; Wu SC; Capece JA; Rosenthal NR
    J Clin Psychiatry; 2007 Feb; 68(2):201-6. PubMed ID: 17335317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial.
    Ziegenhorn AA; Roepke S; Schommer NC; Merkl A; Danker-Hopfe H; Perschel FH; Heuser I; Anghelescu IG; Lammers CH
    J Clin Psychopharmacol; 2009 Apr; 29(2):170-3. PubMed ID: 19512980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients.
    Abdallah CG; Dutta A; Averill CL; McKie S; Akiki TJ; Averill LA; Deakin JFW
    Chronic Stress (Thousand Oaks); 2018; 2():. PubMed ID: 30263977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder.
    Dunlop BW; Binder EB; Iosifescu D; Mathew SJ; Neylan TC; Pape JC; Carrillo-Roa T; Green C; Kinkead B; Grigoriadis D; Rothbaum BO; Nemeroff CB; Mayberg HS
    Biol Psychiatry; 2017 Dec; 82(12):866-874. PubMed ID: 28793974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD.
    Brewerton TD; Wang JB; Lafrance A; Pamplin C; Mithoefer M; Yazar-Klosinki B; Emerson A; Doblin R
    J Psychiatr Res; 2022 May; 149():128-135. PubMed ID: 35272210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.
    Krystal JH; Rosenheck RA; Cramer JA; Vessicchio JC; Jones KM; Vertrees JE; Horney RA; Huang GD; Stock C;
    JAMA; 2011 Aug; 306(5):493-502. PubMed ID: 21813427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
    Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE
    Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized, Placebo-Controlled Trial of Mirtazapine for the Treatment of Posttraumatic Stress Disorder in Veterans.
    Davis LL; Pilkinton P; Lin C; Parker P; Estes S; Bartolucci A
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33084254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
    Taylor F; Raskind MA
    J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.
    Davidson J; Pearlstein T; Londborg P; Brady KT; Rothbaum B; Bell J; Maddock R; Hegel MT; Farfel G
    Am J Psychiatry; 2001 Dec; 158(12):1974-81. PubMed ID: 11729012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of Prolonged Exposure for PTSD in U.S. combat veterans.
    Lehrner A; Hildebrandt T; Bierer LM; Flory JD; Bader HN; Makotkine I; Yehuda R
    Behav Res Ther; 2021 Sep; 144():103924. PubMed ID: 34298438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ifenprodil tartrate treatment of adolescents with post-traumatic stress disorder: A double-blind, placebo-controlled trial.
    Sasaki T; Hashimoto K; Niitsu T; Hosoda Y; Oda Y; Shiko Y; Ozawa Y; Kawasaki Y; Kanahara N; Shiina A; Hashimoto T; Suzuki T; Sugawara T; Hanaoka H; Iyo M
    Psychiatry Res; 2022 May; 311():114486. PubMed ID: 35263680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.
    Davis LL; Jewell ME; Ambrose S; Farley J; English B; Bartolucci A; Petty F
    J Clin Psychopharmacol; 2004 Jun; 24(3):291-7. PubMed ID: 15118483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.